The 10th international conference on ATTD(Advanced Technologies & Treatments for Diabetes) is held in Paris on February 17th. PixoTest Blood Glucose Monitoring System(PixoTest BGMS) is presented by Dr. Freckmann and Nina Jendrike from IDT(Institute of Diabetes-Technology), demonstrating the quality of the novel technology. Last July, research from IDT showed that…

PixoTest Blood Glucose Monitoring System is running an on-line marketing in Switzerland & German now. People who are interested can get a free kit for testing. They can also buy it from Galaxus, the biggest on-line shop in Switzerland. The innovation drew lots of attention. Come and check it out!…

iXensor is very proud to be chosen as top 12 innovations from 400 non- categorized competitors by Nokia Open Innovation Challenge! We’re invited to Paris to have pitch and workshop with other talented startups. It’s a great honor to have the chance to introduce our innovative technology!

PixoTest Blood Glucose Monitoring System received approval from TFDA! Beam, Our distributor of PixoTest BGMS in Taiwan, will coordinate with iXensor to promote the new technology of glucose self-testing.

This July, IDT (Institute of Diabetes-Technology) report shows that PixoTest Blood Glucose Monitoring System got 98% accuracy. It meets the requirement of ISO 15197:2013.

iXensor announces that PixoTest™ system is selected as one of the best six companies in the eHealth Venture Summit and Innovation Award in MEDICA 2014. iXensor gives a presentation about PixoTest™ system at MEDICA 2014 in Dusseldorf, Germany.

iXensor Co. Ltd. announces that it received the approval of CE mark in July, 2014. The approval of CE mark for the self-monitoring glucose system, PixoTest and its smartphone app, PixoHealth, is significant for initiating market in Europe by the end of 2014. iXensor aims to introduce the simpler way…

Taipei, Taiwan- iXensor co. ltd. is pleased to announce that it has completed a growth financing at the end of 2013 totaling US$ 5 million, the round came from existing and new investors which are leading investment management groups in Taiwan interested in supporting the development of innovative medical device…